Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* S&P 500, Nasdaq on track for six-day advance * Netflix up after results, Facebook gains on update * Allergan soars as Ackman and Valeant bid for company * Indexes up: Dow 0.6 pct, S&P 0.5 pct, Nasdaq 0.9 pct (Updates to midday trading) By Ryan Vlastelica NEW YORK
Read more
Pharmaceuticals and biotechnology stocks were rising by an average of six per cent in London on Tuesday, helped by a wave of high-profile M&A deals across the global healthcare sector. Leading the charge in the UK was AstraZeneca on reports that it could be at the centre of the largest deal in phar
Read more(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) April 22 (Reuters) - U.S. stocks rose on Tuesday, with both the S&P 500 and Nasdaq on track
Read moreAstraZeneca was rising strongly on speculation that Pfizer could make a takeover approach for the company, in a transaction valued in the region of 60bn pounds, representing the biggest deal ever in the industry's history and the largest foreign takeover of a UK business on record. While AstraZene
Read more* S&P 500, Nasdaq on track for six-day advance * Netflix up after results, Facebook gains on update * Allergan soars as Ackman and Valeant bid for company * Indexes up: Dow 0.4 pct, S&P 0.4 pct, Nasdaq 0.7 pct
(Updates to open, adds housing data) By Ryan Vlastelica
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that, along with Theravance Inc, it will be launching a phase III study for the combination treatment of fluticasone furoate/vilanterol for chronic obstructive pulmonary disease. Glaxo said that positive results from the study would
Read more* S&P 500, Nasdaq coming off five-day advances * Netflix jumps, results show strong subscriber growth * Travelers and United Tech profits top expectations * Futures up: Dow 6 pts, S&P 0.7 pt, Nasdaq 2.25 pts (Adds McDonald's results) By Ryan Vlastelica NEW YORK, Ap
Read moreSociete Generale has kept a 'sell' recommendation on AstraZeneca (AZN), questioning the reasoning behind a potential takeover by US pharmaceutical peer Pfizer. Societe said: "In our view, given AZN's forecast revenue and earnings profile through 2018-2019 (an earnings decline until 2018), which is
Read moreKillik has maintained a 'buy' recommendation on GlaxoSmithKline (GSK), saying that the company's major three-part transaction with Swiss pharmaceuticals peer Novartis on Tuesday will accelerate growth, provide cost savings and generate increased returns. The first part of the deal will see GSK and
Read moreLONDON (Alliance News) - Pharmaceutical stocks are reigning over the first session following the long Easter bank holiday, with mergers and acquisitions leading investor interest.
GlaxoSmithKline has signed a three-part inter-conditional transaction with Swiss healt
- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,741.04 +2.28% FTSE 100 6,691.88 +1.01% FTSE 250 16,103.19 +1.23% Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tues
Read more* S&P 500, Nasdaq coming off five-day advances * Netflix jumps, results show strong subscriber growth * Rail stocks could benefit from delay in Keystone pipeline * Futures up: Dow 11 pts, S&P 0.6 pt, Nasdaq 9.75 pts By Ryan Vlastelica NEW YORK, April 22 (Reuters) - U
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 - WINNERS
-------
AstraZeneca, up 7.1%. The pharmaceutical company has jumped after The Sunday
LONDON (Alliance News) - The following is a summary of top news stories Tuesday.
----------
COMPANIES
----------
GlaxoSmithKline PLC said it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off i
LONDON, April 22 (Reuters) - Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GlaxoSmithKline and reports U.S. giant Pfizer had approached Britain's AstraZeneca over a deal. Pfizer and Astr
Read more
Last checked at